Vizient serves a diverse membership and customer base that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers.
“Becoming an approved Vizient supplier gives Tru-D the opportunity to deliver enhanced savings on its unique, automated UV disinfection robot’s clinical differentiation and value proposition to Vizient’s membership of academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers who access the Vizient contract portfolio,” said Chuck Dunn, CEO and President of Tru-D SmartUVC. “We are excited to work with Vizient and look forward to a long-term relationship while delivering a rapid return on investment to members.”
Tru-D is the pioneer of no-touch UV disinfection taking to market the world’s first UV robot in 2007 and continually providing industry-leading innovation over the past decade. Tru-D is the only device of its kind backed by a CDC-funded, randomized clinical trial. Results of the landmark Benefits of Enhanced Terminal Room Disinfection (BETR-D) study proved that enhanced terminal room disinfection strategies including Tru-D decreased the risk of acquiring an infection among patients admitted to the same room by a cumulative 30%.
